Association between Abnormal Liver Function and Risk Factors for Metabolic Syndrome among Freshmen

Journal of Adolescent Health

Volumn 41, Issue 2, 2007, Pages 132-137

  Tsai, Ping Yun ^a   Yen, Chung Jen ^b   Li, Yi Chin ^b   Chiu, Tai Yuan ^a   Chen, Ching Yu ^a   Jan, Chyi Feng ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Abnormal liver function; Freshmen; Metabolic syndrome; Nonalcoholic fatty liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LIVER DISEASE; LIVER FUNCTION TEST; MALE; METABOLIC SYNDROME X; OBESITY; PARAMETER; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TAIWAN; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; ALANINE TRANSAMINASE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FATTY LIVER; FEMALE; HUMANS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; OBESITY; RISK FACTORS; STUDENTS; TAIWAN; TRIGLYCERIDES;

EID: 34447297534     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2007.03.002     Document Type: Article

References (40)

1. Clark J.M., Brancati F.L., and Diehl A.M. Nonalcoholic fatty liver disease. Gastroenterology 122 (2002) 1649-1657
2. Marchesini G., Brizi M., Bianchi G., et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50 (2001) 1844-1850
3. Brunt E.M. Nonalcoholic steatohepatitis. Semin Liver Dis 24 (2004) 3-20
4. Cruz M.L., Shaibi G.Q., Weigensberg M.J., et al. Pediatric obesity and insulin resistance: chronic disease risk and implications for treatment and prevention beyond body weight modification. Annu Rev Nutr 25 (2005) 435-468
5. Daniel S., Ben-Menachem T., Vasudevan G., et al. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients. Am J Gastroenterol 94 (1999) 3010-3014
6. Clark J.M., Brancati F.L., and Diehl A.M. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 98 (2003) 960-967
7. Chen D.S., and Sung J.L. Hepatitis B virus infection on Taiwan. N Engl J Med 297 (1977) 668-669
8. Chien Y.C., Jan C.F., Kuo H.S., et al. Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched. Epidemiol Rev 28 (2006) 126-135
9. Jan C.F., Chen C.J., Chiu Y.H., et al. A population-based study investigating the association between metabolic syndrome and hepatitis B/C infection (Keelung Community-based Integrated Screening study No. 10). Int J Obes (Lond) 30 (2006) 794-799
10. Hwang L.C., Bai C.H., and Chen C.J. Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Assoc 105 (2006) 626-635
11. Alberti K.G., Zimmet P., and Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 366 (2005) 1059-1062
12. Tan C.E., Ma S., Wai D., et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?. Diabetes Care 27 (2004) 1182-1186
13. Bureau of Health Promotion, Department of Health, Taiwan. The Criteria of Metabolic Syndrome (2005)
14. Ruhl C.E., and Everhart J.E. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 124 (2003) 71-79
15. Kangro H.O., Osman H.K., Lau Y.L., et al. Seroprevalence of antibodies to human herpesviruses in England and Hong Kong. J Med Virol 43 (1994) 91-96
16. Shen Y.H., Yang W.S., Lee T.H., et al. Bright liver and alanine aminotransferase are associated with metabolic syndrome in adults. Obes Res 13 (2005) 1238-1245
17. Fan J.G., Zhu J., Li X.J., et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol 43 (2005) 508-514
18. Hamaguchi M., Kojima T., Takeda N., et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 143 (2005) 722-728
19. Liangpunsakul S., and Chalasani N. Relationship between unexplained elevations in alanine aminotransferase and serum leptin in U.S. adults: results from the Third National Health and Nutrition Examination Survey (NHANES III). J Clin Gastroenterol 38 (2004) 891-897
20. Park H.S., Han J.H., Choi K.M., et al. Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents. Am J Clin Nutr 82 (2005) 1046-1051
21. Bedogni G., Miglioli L., Masutti F., et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 42 (2005) 44-52
22. Rocha R., Cotrim H.P., Carvalho F.M., et al. Body mass index and waist circumference in non-alcoholic fatty liver disease. J Hum Nutr Diet 18 (2005) 365-370
23. Guzzaloni G., Grugni G., Minocci A., et al. Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test. Int J Obes Relat Metab Disord 24 (2000) 772-776
24. Manton N.D., Lipsett J., Moore D.J., et al. Non-alcoholic steatohepatitis in children and adolescents. Med J Aust 173 (2000) 476-479
25. Schwimmer J.B., Deutsch R., Rauch J.B., et al. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 143 (2003) 500-505
26. Chan D.F., Li A.M., Chu W.C., et al. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord 28 (2004) 1257-1263
27. Janssen I., Heymsfield S.B., Allison D.B., et al. Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat. Am J Clin Nutr 75 (2002) 683-688
28. Taylor R.W., Jones I.E., Williams S.M., et al. Evaluation of waist circumference, waist-to-hip ratio, and the conicity index as screening tools for high trunk fat mass, as measured by dual-energy X-ray absorptiometry, in children aged 3-19 y. Am J Clin Nutr 72 (2000) 490-495
29. Wang J. Waist circumference: a simple, inexpensive, and reliable tool that should be included as part of physical examinations in the doctor's office. Am J Clin Nutr 78 (2003) 902-903
30. Sanyal A.J. Mechanisms of disease: pathogenesis of nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol 2 (2005) 46-53
31. Kahn H.S., and Valdez R. Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration. Am J Clin Nutr 78 (2003) 928-934
32. Perseghin G., Bonfanti R., Magni S., et al. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease. Am J Physiol Endocrinol Metab 291 (2006) E697-E703
33. Berenson G.S., Srinivasan S.R., Cresanta J.L., et al. Dynamic changes of serum lipoproteins in children during adolescence and sexual maturation. Am J Epidemiol 113 (1981) 157-170
34. Boulton T.J., Magarey A.M., and Cockington R.A. Serum lipids and apolipoproteins from 1 to 15 years: changes with age and puberty, and relationships with diet, parental cholesterol and family history of ischaemic heart disease. Acta Paediatr 84 (1995) 1113-1118
35. Harrell J.S., Jessup A., and Greene N. Changing our future: obesity and the metabolic syndrome in children and adolescents. J Cardiovasc Nurs 21 (2006) 322-330
36. Raitakari O.T., Porkka K.V., Ronnemaa T., et al. The role of insulin in clustering of serum lipids and blood pressure in children and adolescents. The Cardiovascular Risk in Young Finns Study. Diabetologia 38 (1995) 1042-1050
37. Cruz M.L., Weigensberg M.J., Huang T.T., et al. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab 89 (2004) 108-113
38. Berenson G.S., Radhakrishnamurthy B., Srinivasan S.R., et al. Plasma glucose and insulin levels in relation to cardiovascular risk factors in children from a biracial population-the Bogalusa Heart Study. J Chronic Dis 34 (1981) 379-391
39. Bergstrom E., Hernell O., Persson L.A., et al. Insulin resistance syndrome in adolescents. Metabolism 45 (1996) 908-914
40. Choudhury J., and Sanyal A.J. Clinical aspects of fatty liver disease. Semin Liver Dis 24 (2004) 349-362